North Carolina removed GLP-1s from its preferred drug list for weight loss in October 2025, though coverage for cardiovascular and other non-obesity indications continues with prior authorization
Options moving forward For those who were using compounded tirzepatide, potential alternatives include: Injectable versions of tirzepatide: Mounjaro for type 2 diabetes and Zepbound for weight loss Injectable semaglutide: Ozempic for type 2 diabetes and Wegovy for weight loss Oral semaglutide (Rybelsus) for type 2 diabetes Oral diabetes medications like metformin Older-generation antiobesity medication Note: This content is for educational purposes only
Obesity is a chronic disease, not a character flawwe continue to actively confront the stigma and bias associated with it and advocate for access to support and care, Novo Nordisk said in a Feb
At its core is Semaglutide, a powerful GLP-1 receptor agonist known to reduce appetite and support blood sugar regulation
Easy measuring: At 333.3 mg/mL, 1 unit = 0.01 mL = 3.33 mg on a U100 insulin syringe
The mayor and his mother will have much to celebrate this Mothers Day, including their legacy of serving their growing community
